These benefits, together with a former report exhibiting that a small-molecule ACKR3 agonist CCX771 exhibits anxiolytic-like behavior in mice,2 help the principle of targeting ACKR3 as a novel strategy to modulate the opioid procedure, which could open new therapeutic avenues for opioid-similar Ailments. January 3, 2024 Donating is a https://confuciusl384zph9.qodsblog.com/profile